Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

How Doctors Judge Whether a Medical Study Can Be Trusted

1The Clinical Question and Why Study Design Follows From It2Randomization, Allocation, and the Logic of Comparison3Blinding, Follow-Up, and Who Actually Got Analyzed4Reading the Result: Effect Size, Uncertainty, and Significance5Applicability: Does This Result Fit My Patient?6Combining Studies and Forming a Verdict
Combining Studies and Forming a Verdict

From Certainty to a Recommendation

4 / 4
The example on this page shows the full move from certainty to a recommendation. The evidence was rated low certainty. The recommendation is still to offer the drug — but weakly, and with the reasoning spelled out: the pooled estimate favors the drug, but the evidence has specific problems, the absolute benefit depends on baseline risk, and the drug carries adverse effects. Notice the two judgments being kept separate. Certainty is about the evidence; strength is about the decision. A weak recommendation on low-certainty evidence is not a contradiction — it is the honest combination. And notice that the reasoning names the exact problems that produced the low rating, so a colleague can challenge the recommendation by challenging any of those judgments. That transparency is what makes the verdict defensible.
0:00 / 0:00

Three parts of a defensible recommendation

A recommendation that can be examined and challenged states three things explicitly.

  • Direction: recommend for, recommend against, or recommend either option.
  • Strength: strong (most informed patients would choose it) or weak/conditional (the right choice depends on the patient's values and circumstances).
  • Reasoning: the certainty of evidence, the balance of benefits and harms, the values and preferences at stake, and any resource considerations.

A recommendation with its reasoning

Using the low-certainty body of evidence from the previous page: 'We suggest offering the drug to patients with established cardiovascular disease (weak recommendation, low-certainty evidence). The pooled estimate suggests a reduction in the composite cardiovascular outcome, but the evidence is limited by unclear allocation concealment in two trials, unexplained heterogeneity, and possible publication bias. The absolute benefit depends on the patient's baseline risk and is likely small for lower-risk patients. Because the benefit is uncertain and the drug carries a small risk of adverse effects, the decision should be made with the patient, taking into account their baseline risk and their tolerance for uncertainty.' Notice that the direction is for, the strength is weak, and the reasoning names the certainty rating and the specific problems that produced it.

Strength is not the same as certainty

A strong recommendation can rest on low-certainty evidence when the consequences of being wrong are asymmetric — for example, a treatment for a condition that is otherwise uniformly fatal. Conversely, a weak recommendation can rest on high-certainty evidence when benefits and harms are closely balanced or when patient values differ substantially. Do not read a strong recommendation as a claim that the evidence is strong.

References

  1. [1]GRADE Handbook: Going from evidence to recommendationsgdt.gradepro.org
Previous4 / 4Complete

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion